Literature DB >> 26883725

T-bet expression by Th cells promotes type 1 inflammation but is dispensable for colitis.

J Zimmermann1, A A Kühl2, M Weber1, J R Grün1, J Löffler1, C Haftmann1, R Riedel1, P Maschmeyer1, K Lehmann1, K Westendorf1, M-F Mashreghi1, M Löhning1, M Mack3, A Radbruch1, H D Chang1.   

Abstract

The transcription factor T-bet is highly expressed by Th cells isolated from the inflamed intestine of Crohn's disease patients, and has been regarded a critical driver of murine T cell-induced colitis. However, we show here that T-bet expression by Th cells is not required for the manifestation of T-cell-induced colitis in the presence of segmented filamentous bacteria and Helicobacter hepaticus. T-bet expression by Th cells controls their survival and localization, their repertoire of chemokine and chemokine receptor expression, the accumulation of monocytes and macrophages in the inflamed colon, and their differentiation to the M1 type, i.e., type 1 inflammation. Nevertheless, T-bet-deficient Th cells efficiently induce colitis, as reflected by weight loss, diarrhea, and colon histopathology. T-bet-deficient Th cells differentiate into Th1/17 cells, able to express IFN-γ and IL-17A upon restimulation. While neutralization of IL-17A exacerbated colitis induced by wild-type or T-bet-deficient Th cells, neutralization of IFN-γ completely abolished colitis.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26883725     DOI: 10.1038/mi.2016.5

Source DB:  PubMed          Journal:  Mucosal Immunol        ISSN: 1933-0219            Impact factor:   7.313


  51 in total

1.  Double deficiency for RORγt and T-bet drives Th2-mediated allograft rejection in mice.

Authors:  Manije Sabet-Baktach; Elke Eggenhofer; Jordi Rovira; Philipp Renner; Margareta Lantow; Stefan A Farkas; Muriel Malaisé; Karoline Edtinger; Zhou Shaotang; Gudrun E Koehl; Marc H Dahlke; Hans J Schlitt; Edward K Geissler; Alexander Kroemer
Journal:  J Immunol       Date:  2013-09-20       Impact factor: 5.422

2.  Cutting edge: the pathogenicity of IFN-γ-producing Th17 cells is independent of T-bet.

Authors:  Rebekka Duhen; Simon Glatigny; Carlos A Arbelaez; Tiffany C Blair; Mohamed Oukka; Estelle Bettelli
Journal:  J Immunol       Date:  2013-03-29       Impact factor: 5.422

3.  Distinct effects of T-bet in TH1 lineage commitment and IFN-gamma production in CD4 and CD8 T cells.

Authors:  Susanne J Szabo; Brandon M Sullivan; Claudia Stemmann; Abhay R Satoskar; Barry P Sleckman; Laurie H Glimcher
Journal:  Science       Date:  2002-01-11       Impact factor: 47.728

4.  Sialic acid-binding Ig-like lectin 1 expression in inflammatory and resident monocytes is a potential biomarker for monitoring disease activity and success of therapy in systemic lupus erythematosus.

Authors:  Robert Biesen; Cemal Demir; Fidan Barkhudarova; Joachim R Grün; Marta Steinbrich-Zöllner; Marina Backhaus; Thomas Häupl; Martin Rudwaleit; Gabriela Riemekasten; Andreas Radbruch; Falk Hiepe; Gerd-Rüdiger Burmester; Andreas Grützkau
Journal:  Arthritis Rheum       Date:  2008-04

5.  The roles of CCR6 in migration of Th17 cells and regulation of effector T-cell balance in the gut.

Authors:  C Wang; S G Kang; J Lee; Z Sun; C H Kim
Journal:  Mucosal Immunol       Date:  2009-01-07       Impact factor: 7.313

6.  IL-1β mediates chronic intestinal inflammation by promoting the accumulation of IL-17A secreting innate lymphoid cells and CD4(+) Th17 cells.

Authors:  Margherita Coccia; Oliver J Harrison; Chris Schiering; Mark J Asquith; Burkhard Becher; Fiona Powrie; Kevin J Maloy
Journal:  J Exp Med       Date:  2012-08-13       Impact factor: 14.307

7.  Interleukin-23 drives intestinal inflammation through direct activity on T cells.

Authors:  Philip P Ahern; Chris Schiering; Sofia Buonocore; Mandy J McGeachy; Dan J Cua; Kevin J Maloy; Fiona Powrie
Journal:  Immunity       Date:  2010-08-27       Impact factor: 31.745

8.  Nonlymphocyte-derived tumor necrosis factor is required for induction of colitis in recombination activating gene (RAG)2(-/-) mice upon transfer of CD4(+)CD45RB(hi) T cells.

Authors:  N Corazza; S Eichenberger; H P Eugster; C Mueller
Journal:  J Exp Med       Date:  1999-11-15       Impact factor: 14.307

9.  Bim/Bcl-2 balance is critical for maintaining naive and memory T cell homeostasis.

Authors:  Sara Wojciechowski; Pulak Tripathi; Tristan Bourdeau; Luis Acero; H Leighton Grimes; Jonathan D Katz; Fred D Finkelman; David A Hildeman
Journal:  J Exp Med       Date:  2007-06-25       Impact factor: 14.307

10.  Phenotypic and functional features of human Th17 cells.

Authors:  Francesco Annunziato; Lorenzo Cosmi; Veronica Santarlasci; Laura Maggi; Francesco Liotta; Benedetta Mazzinghi; Eliana Parente; Lucia Filì; Simona Ferri; Francesca Frosali; Francesco Giudici; Paola Romagnani; Paola Parronchi; Francesco Tonelli; Enrico Maggi; Sergio Romagnani
Journal:  J Exp Med       Date:  2007-07-16       Impact factor: 14.307

View more
  16 in total

1.  T-lymphocyte-derived enkephalins reduce Th1/Th17 colitis and associated pain in mice.

Authors:  Lilian Basso; Laure Garnier; Arnaud Bessac; Jérôme Boué; Catherine Blanpied; Nicolas Cenac; Sophie Laffont; Gilles Dietrich
Journal:  J Gastroenterol       Date:  2017-04-19       Impact factor: 7.527

2.  Murine T-Cell Transfer Colitis as a Model for Inflammatory Bowel Disease.

Authors:  Patrick Maschmeyer; Jakob Zimmermann; Anja Andrea Kühl
Journal:  Methods Mol Biol       Date:  2021

3.  TNF-α Contributes to Lymphoid Tissue Disorganization and Germinal Center B Cell Suppression during Intracellular Bacterial Infection.

Authors:  Maria Popescu; Berenice Cabrera-Martinez; Gary M Winslow
Journal:  J Immunol       Date:  2019-09-30       Impact factor: 5.422

Review 4.  Immunological memory in rheumatic inflammation - a roadblock to tolerance induction.

Authors:  Patrick Maschmeyer; Hyun-Dong Chang; Qingyu Cheng; Mir-Farzin Mashreghi; Falk Hiepe; Tobias Alexander; Andreas Radbruch
Journal:  Nat Rev Rheumatol       Date:  2021-04-06       Impact factor: 20.543

5.  CD96 expression determines the inflammatory potential of IL-9-producing Th9 cells.

Authors:  Katarina Stanko; Christina Iwert; Christine Appelt; Katrin Vogt; Julia Schumann; Franziska Janina Strunk; Stefanie Ahrlich; Stephan Schlickeiser; Chiara Romagnani; Karsten Jürchott; Christian Meisel; Gerald Willimsky; Anja A Kühl; Birgit Sawitzki
Journal:  Proc Natl Acad Sci U S A       Date:  2018-03-12       Impact factor: 11.205

6.  The intestinal microbiota determines the colitis-inducing potential of T-bet-deficient Th cells in mice.

Authors:  Jakob Zimmermann; Pawel Durek; Anja A Kühl; Florian Schattenberg; Patrick Maschmeyer; Francesco Siracusa; Katrin Lehmann; Kerstin Westendorf; Melanie Weber; René Riedel; Susann Müller; Andreas Radbruch; Hyun-Dong Chang
Journal:  Eur J Immunol       Date:  2017-09-29       Impact factor: 5.532

7.  Genetic variants alter T-bet binding and gene expression in mucosal inflammatory disease.

Authors:  Katrina Soderquest; Arnulf Hertweck; Claudia Giambartolomei; Stephen Henderson; Rami Mohamed; Rimma Goldberg; Esperanza Perucha; Lude Franke; Javier Herrero; Vincent Plagnol; Richard G Jenner; Graham M Lord
Journal:  PLoS Genet       Date:  2017-02-10       Impact factor: 5.917

8.  Changes in γδT Cells in Peripheral Blood of Patients with Ulcerative Colitis Exacerbations.

Authors:  Andrzej Gryglewski; Piotr Richter; Marian Szczepanik
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2021-07-21       Impact factor: 4.291

9.  T-bet is a key modulator of IL-23-driven pathogenic CD4(+) T cell responses in the intestine.

Authors:  Thomas Krausgruber; Chris Schiering; Krista Adelmann; Oliver J Harrison; Agnieszka Chomka; Claire Pearson; Philip P Ahern; Matthew Shale; Mohamed Oukka; Fiona Powrie
Journal:  Nat Commun       Date:  2016-05-19       Impact factor: 14.919

10.  Divergent Roles of Interferon-γ and Innate Lymphoid Cells in Innate and Adaptive Immune Cell-Mediated Intestinal Inflammation.

Authors:  Jennifer Brasseit; Cheong K C Kwong Chung; Mario Noti; Daniel Zysset; Nina Hoheisel-Dickgreber; Vera Genitsch; Nadia Corazza; Christoph Mueller
Journal:  Front Immunol       Date:  2018-01-24       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.